(Q40263137)

English

Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study

scientific article published on 28 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study (English)

1 reference

Europe PubMed Central

19 September 2017

0 references

multicenter clinical trial

0 references

Werner J. Heinz

0 references

author name string

G Maschmeyer

1

1 reference

Europe PubMed Central

19 September 2017

W J Heinz

2

1 reference

Europe PubMed Central

19 September 2017

B Hertenstein

3

1 reference

Europe PubMed Central

19 September 2017

H-A Horst

4

1 reference

Europe PubMed Central

19 September 2017

C Requadt

5

1 reference

Europe PubMed Central

19 September 2017

T Wagner

6

1 reference

Europe PubMed Central

19 September 2017

O A Cornely

7

1 reference

Europe PubMed Central

19 September 2017

J Löffler

8

1 reference

Europe PubMed Central

19 September 2017

M Ruhnke

9

1 reference

Europe PubMed Central

19 September 2017

IDEA study investigators

10

1 reference

Europe PubMed Central

19 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

28 December 2012

1 reference

Europe PubMed Central

19 September 2017

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

19 September 2017

32

1 reference

Europe PubMed Central

19 September 2017

5

1 reference

Europe PubMed Central

19 September 2017

679-689

1 reference

Europe PubMed Central

19 September 2017

https://scigraph.springernature.com/pub.10.1007/s10096-012-1794-4

0 references

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Optimizing antimicrobial therapy in sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Epidemiology of visceral mycoses in autopsy cases in Japan: comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in Annual of Pathological Autopsy Cases in Japan

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Aspergillus PCR: one step closer to standardization.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Recommendations for the treatment of established fungal infections

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1794-4

21 January 2018

Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Between over- and undertreatment of invasive fungal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-012-1794-4

1 reference

Europe PubMed Central

19 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40263137&oldid=1891333004"